Forbes J M & Co LLP
- SEC CIK
- 0001067532
- Latest filing
- Jul 20, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Forbes J M & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,316
- Value
- $300.0K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,316 | $300.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,316 | $265.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,316 | $282.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,316 | $257.9K | <0.1% | −1,153−25.8% | Reduced | Holders |
| Q2 2025 | 4,469 | $349.5K | <0.1% | −816−15.4% | Reduced | Holders |
| Q1 2025 | 5,285 | $383.1K | <0.1% | −325−5.8% | Reduced | Holders |
| Q4 2024 | 5,610 | $415.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,610 | $370.2K | <0.1% | +325+6.1% | Added | Holders |
| Q2 2024 | 5,285 | $488.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,285 | $505.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 5,285 | $403.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 5,285 | $366.1K | <0.1% | −75−1.4% | Reduced | Holders |
| Q2 2023 | 5,360 | $506.0K | 0.1% | +75+1.4% | Added | Holders |
| Q1 2023 | 5,285 | $437.0K | 0.1% | −75−1.4% | Reduced | Holders |
| Q4 2022 | 5,360 | $399.0K | 0.1% | +75+1.4% | Added | Holders |
| Q3 2022 | 5,285 | $436.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,285 | $503.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 5,285 | $622.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 5,285 | $685.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 5,285 | $598.0K | 0.1% | −823−13.5% | Reduced | Holders |
| Q2 2021 | 6,108 | $633.0K | 0.1% | −462−7.0% | Reduced | Holders |
| Q1 2021 | 6,570 | $550.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.